| Unique ID issued by UMIN | UMIN000056978 |
|---|---|
| Receipt number | R000065112 |
| Scientific Title | A verification of the effect of natto powder intake on improving bowel movements in healthy adults : a randomized, double-blind, placebo-controlled study |
| Date of disclosure of the study information | 2026/04/30 |
| Last modified on | 2025/02/08 10:43:08 |
A verification of the effect of natto powder intake on improving bowel movements in healthy adults
A study on the effects of natto powder
A verification of the effect of natto powder intake on improving bowel movements in healthy adults : a randomized, double-blind, placebo-controlled study
A study on the effects of natto powder
| Japan |
Healthy adult
| Not applicable | Adult |
Others
NO
Evaluation of the intentional regulatory effects of natto powder intake in healthy adults
Efficacy
Confirmatory
Stool Consistency Visual Analogue scale
Profile of Mood states 2
Chalder Fatigue Scale
OSA Sleep Inventory MA Version
Fatigue Visual Analog Scale
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
YES
No need to know
2
Prevention
| Food |
To take Natto powder 3g/day for 4 weeks (28 days)
To take Boiled Soybean powder 3g/day for 4 weeks (28 days)
| 30 | years-old | <= |
| 70 | years-old | >= |
Male and Female
(1) persons who is generally judged as healthy
(2) Persons who can give voluntary written consent to participate in the present trial
(3)Person who are aware of their constipation
(1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study
(2) persons who have changed their habitats to take supplements within past 4 weeks.
(3) Persons who work in night shift or in day and night shift
(4) persons who have been treated their illness or prevention in a clinic at their informed consent
(5) persons with their medical histories as follows: serious diseases of sugar metabolism, lipid metabolism, hepatic function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system
(6) persons with the medical histories of alcoholism or drug dependence
(7) persons who might be developed allergic reaction to foods.
(8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study period
(9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device)
(10) persons who will not be judged suitable to the participants by the investigator.
32
| 1st name | Kouichirou |
| Middle name | |
| Last name | Ohnuki |
User Life Science Co.,Ltd.
The research and development part
820-0115
372-3,Niho,Iiduka-shi,Fukuoka,Japan
0948-82-3123
ohnuki.rinp@gmail.com
| 1st name | Keiko |
| Middle name | |
| Last name | Ohnuki |
User Life Science Co.,Ltd.
The research and development part
820-0115
372-3,Niho,Iiduka-shi,Fukuoka,Japan
0948-82-3123
userlifescience@gmail.com
User Life Science Co.,Ltd.
Yamada Foods Co.,Ltd.
Profit organization
Kindai University, Faculty of humanity-oriented science and engineering, Ethics Committee
11-6,Kayanomori,Iiduka-shi,Fukuoka,Japan
0948-22-5655
ohnuki@fuk.kindai.ac.jp
NO
| 2026 | Year | 04 | Month | 30 | Day |
Unpublished
32
No longer recruiting
| 2025 | Year | 01 | Month | 15 | Day |
| 2024 | Year | 03 | Month | 06 | Day |
| 2025 | Year | 01 | Month | 24 | Day |
| 2025 | Year | 04 | Month | 30 | Day |
| 2025 | Year | 02 | Month | 08 | Day |
| 2025 | Year | 02 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000065112